Scientists from Paul Scherrer Institute and University College London developed bioactive nanoparticles that cleared toxic proteins in mice, reversing Alzheimer’s symptoms and restoring cognition, offering a potential shift toward vascular repair-based therapies for neurodegenerative diseases
The results could aid the development of treatments that halt the progression of cell damage after brain injury, which can otherwise lead to neurological diseases such as amyotrophic lateral sclerosis (ALS), and Alzheimer's and Parkinson's disease.
